Supplement Amino Acid
The purpose of the study is to confirm the results of a prior study that demonstrated pills containing two amino acids which are in foods increased growth hormone and insulin-like growth factor-1.
|Study Design:||Allocation: Randomized
Endpoint Classification: Pharmacodynamics Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Basic Science
|Official Title:||Growth Hormone 120 Minutes Following a Single Low-dose of Amino Acids in Healthy Subjects.|
- Quantity of Growth Hormone [ Time Frame: 3 Weeks ] [ Designated as safety issue: No ]Measure human growth hormone at times -30, -15, 0, 30, 60, 90, and 120 minutes on two occasions about one week apart. On one occasion, the proprietary amino acid derivative blend will be given orally at time 0 in capsule form, and on the other occasion the capsules will contain no amino acids.
- Insulin-like growth factor 1 [ Time Frame: 3 Weeks ] [ Designated as safety issue: No ]Measure IGF-1 eight hours following the administration of the capsules containing the proprietary amino acid derivative blend or placebos.
|Study Start Date:||October 2011|
|Study Completion Date:||March 2012|
|Primary Completion Date:||December 2011 (Final data collection date for primary outcome measure)|
Active Comparator: amino acid supplement
supplements with the proprietary amino acid derivative blend.
Drug: Amino acid supplement
An orally administered supplement of the proprietary amino acid derivative
Placebo Comparator: Placebo
A non-active orally administered supplement of the proprietary amino acid derivative
Oral supplementation with a key combination of derivatives that has been shown to increase human growth hormone in healthy volunteers peaking at 90 minutes and IGF-1 at 8 hours post-administration.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01540773
|United States, Louisiana|
|Pennington Biomedical Research Center|
|Baton Rouge, Louisiana, United States, 70808|